Avelumab in G3 NEC

计划入组 10 人 · 首次发布于 2017 年 9 月 11 日

RIC-NEC Randomized Controlled Trial

计划入组 78 人 · 首次发布于 2022 年 3 月 15 日

NEC Thermography Infrared Imaging Study

计划入组 12 人 · 首次发布于 2019 年 6 月 21 日

Nec-3

WT1-W10 peptide vaccine(NEC Corp.)

Undisclosed,NEC Corp(Influenza,Prophylactic vaccine)

NEC OncoImmunity AS

Norway

NEC CORPORATION

Japan

Neo Performance Materials Inc

United States

CEPI Awards $5 Million to Nagasaki University for Revolutionary 'Nanoball' mRNA Vaccine Platform

CEPI Awards $5 Million to Nagasaki University for AI-Powered Nanoball mRNA Vaccine Platform Against Disease X

TG4050 Neoantigen Vaccine Shows Sustained Disease-Free Survival in Head and Neck Cancer Trial